Prothena reported $-0.68 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD 0.03 0.13 Mar/2025
ALKERMES USD 0.49 0.03 Sep/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Prothena USD -0.68 1.66 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xoma USD -1.59 2.43 Sep/2024